DAVID R ZETTER MD NPI 1598711756

NPI Details

David R Zetter, MD is a general practice in Arlington, KY with 36 years of experience. The provider is a physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions. Source: National Uniform Claim Committee David R Zetter, MD NPI is 1598711756. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

100 STATE ROUTE 80 E
ARLINGTON, KY
ZIP 42021-016
Phone: (270) 267-0051
Fax: (270) 251-4546

The NPI 1598711756 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 18D0910992 - physician office with a certificate type of Certificate for Provider-Performed Microscopy Procedures (PPMP).

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Initial nursing facility visit per day, typically 25 minutes (HCPCS:99304)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Initial nursing facility visit per day, typically 35 minutes (HCPCS:99305)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Initial nursing facility visit per day, typically 25 minutes (HCPCS:99304)
• Initial nursing facility visit per day, typically 35 minutes (HCPCS:99305)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Urinalysis, manual test (HCPCS:81002)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Follow-up nursing facility visit per day, typically 10 minutes (HCPCS:99307)
• Nursing facility discharge day management, 30 minutes or less (HCPCS:99315)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 5/26/2006 and was last updated on 12/1/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.